Survodutide is a synthetic research peptide catalogued in the incretin family — one of the multi-target compounds, described in the literature as a GLP-1/glucagon dual receptor agonist. It sits in the incretin and appetite-pathway research collection alongside the other multi-target reference peptides.
Vestrand carries it as one consistent reference lot at a time, characterised by an independent laboratory, with that lot's certificate of analysis published to its verification page once the work is complete.
One point of care is worth stating plainly. This item is listed under the name Survodutide, development code BI 456906; it has circulated elsewhere under a garbled name, so Vestrand keys the product to its recognised identity and confirms each lot by certificate rather than by label. Its molecular record is still being sourced, so those fields are shown as pending rather than filled from expectation. Purity is stated as one specification and confirmed for each lot.
For laboratory research use only. Not for human or veterinary use.